Disease/Infection News

RSS

New general manager's banking background beneficial at Global Fund

In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."

1 Feb 2012

Peptides linked with internal flu viral structures can help develop universal vaccine

Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu.

1 Feb 2012

U.N. provides $9.1M to WHO, UNICEF to help fight cholera in DRC

The Democratic Republic of the Congo (DRC) last week "received $9.1 million ... from the United Nations Central Emergency Response Fund (CERF) to fight off cholera, which has affected more than 22,000 people and killed 500 over the past year in the central African country," the U.N. News Centre reports.

1 Feb 2012

Opinion pieces, blog react to new public-private NTD initiative

Pharmaceutical company heads and global health leaders gathered at a conference on Monday in London to announce the formation of a large public-private partnership to fight neglected tropical diseases (NTDs) and endorse the "London Declaration on Neglected Tropical Diseases", in which they pledged to work together and track progress.

1 Feb 2012

Opinion pieces recognize Global Fund anniversary

Last week, the Global Fund to Fight AIDS, Tuberculosis and Malaria celebrated its 10-year anniversary. The following are summaries of two opinion pieces written in recognition of this milestone.

1 Feb 2012

ASM to publish special commentaries on NSABB and H5N1 research

In response to recent actions of the U.S. National Science Advisory Board for Biosecurity (NSABB), which recommended that two scientific journals withhold crucial details in upcoming reports about experiments with a novel strain of the bird flu virus, H5N1, the American Society for Microbiology (ASM) will publish a special series of commentaries by prominent scientists, including the acting chair of the NSABB, weighing in on whether the recommendations were necessary and what role biosecurity considerations should play in the dissemination of research findings.

1 Feb 2012

Media outlets continue to publish expert opinion regarding H5N1 bird flu research

The PBS NewsHour blog "The Rundown" features excerpts from interviews with three experts discussing the recent debate over research conducted on the H5N1 bird flu virus.

1 Feb 2012

Protesting Kenyans call for emergency donor conference to raise $2B for Global Fund

"Hundreds of HIV-positive Kenyans protested outside the European Union's Nairobi office on Monday, accusing the E.U. of causing unnecessary deaths by cutting funding to" the Global Fund to Fight AIDS, Tuberculosis and Malaria, AlertNet reports.

1 Feb 2012

Faster, less expensive methods of circumcision being tested, reviewed, New York Times reports

The New York Times examines developments in circumcision technology, after "three studies have shown that circumcising adult heterosexual men is one of the most effective 'vaccines' against [HIV] -- reducing the chances of infection by 60 percent or more."

1 Feb 2012

Potential way to block second wave of death from pneumonia treatment

An international research team may have found a way to block a second wave of death that can result from pneumonia treatment.

1 Feb 2012

NanoViricides files FluCide pre-IND briefing document with the FDA

NanoViricides, Inc. announced today that it has submitted a pre-IND briefing document to the US FDA. This submission provides the required information for the Company's highly effective anti-influenza drug candidate, FluCide, in support of a pre-IND Meeting.

1 Feb 2012

Certain strains of P. aeruginosa cause WBCs to produce high levels of histamine

Could some cases of asthma actually be caused by an allergic reaction to a common environmental bacteria? New research findings published in the Journal of Leukocyte Biology suggests that this idea may not be as far-fetched as it seems. In a research report appearing in the February 2012 print issue, researchers show a link between common environmental bacteria and airway inflammation.

1 Feb 2012

Hand hygiene, surgical masks can cut spread of flu-like illnesses upto 75%

Masks and hand hygiene could cut the spread of flu-like symptoms up to 75 percent, a University of Michigan study found.

1 Feb 2012

Study identifies norovirus as major cause of all infection outbreaks in U.S. hospitals

Norovirus, a pathogen that often causes food poisoning and gastroenteritis, was responsible for 18.2 percent of all infection outbreaks and 65 percent of ward closures in U.S. hospitals during a two-year period, according to a new study published in the February issue of the American Journal of Infection Control (AJIC), the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

1 Feb 2012

NIAID, Aeras partner for Phase II clinical trial of TB vaccine

Aeras announces today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), has joined as a partner for a Phase II proof-of-concept clinical trial of a tuberculosis vaccine candidate jointly developed by Aeras and Dutch biopharmaceutical company Crucell.

1 Feb 2012

Pneumonic plague bacteria transform lungs into a playground for microbes to flourish

Among medical mysteries baffling many infectious disease experts is exactly how the deadly pneumonic plague bacterium, Yersinia pestis, goes undetected in the first few day of lung infection, often until it's too late for medical treatment.

1 Feb 2012

Researchers investigate Avian Pathogenic E. coli strains

Escherichia coli bacteria thrive in the lower intestine of humans and other animals, including birds. Most are vital constituents of the healthy gut flora, but certain forms of E. coli cause a range of diseases in both humans and poultry.

1 Feb 2012

$Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost$

Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost

Millions of poor Nigerians will gain access to the most effective combination treatment for malaria at a fraction of its current cost, following the successful conclusion of negotiations between the United Kingdom Department for International Development (DFID) funded Partnership for Transforming Health Systems (PATHS2) and a variety of international and national stakeholders in Nigeria this week.

31 Jan 2012

Major effort to tackle neglected tropical diseases

Thirteen drug companies, the governments of the United States, Britain and the United Arab Emirates, the World Bank, the Bill and Melinda Gates Foundation, the Lions Club and other smaller charitable organizations on Monday announced a joint effort to tackle 10 neglected tropical diseases in a coordinated fashion.

31 Jan 2012

Large public-private partnership announced to speed progress against NTDs

Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.

31 Jan 2012